Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Rowan E. Chapman | Director | 2024-12-10 | 1,767 | $170.24 | $300.81kSell |
Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2024-12-09 | 3,323 | $12.85 | $42.70kBuy |
Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2024-12-09 | 5,752 | $7.45 | $42.85kBuy |
Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2024-12-09 | 4,858 | $166.59 | $809.31kSell |
Roelof Botha | Director | 2024-12-02 | 11,219 | $170.54 | $1.91MSell |
Roelof Botha | Director | 2024-12-02 | 8,783 | $166.88 | $1.47MSell |
Roelof Botha | Director | 2024-12-02 | 40,171 | $169.78 | $6.82MSell |
Roelof Botha | Director | 2024-12-02 | 16,853 | $168.73 | $2.84MSell |
Roelof Botha | Director | 2024-12-02 | 10,447 | $167.59 | $1.75MSell |
Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 2024-11-26 | 660 | $163.25 | $107.74kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Vanguard Group Inc | 8.66% | 11,437,007 | $1.90B | Institution |
Blackrock Inc 1 | 6.24% | 8,233,006 | $1.37B | Institution |
Claremont Creek Ventures L P | 4.44% | 5,864,630 | $976.17M | Insider |
Roelof Botha | 4.30% | 5,680,997 | $945.60M | Insider |
Sc XII Management LLC | 4.11% | 5,421,122 | $902.35M | Insider |
Matthew Rabinowitz | 3.85% | 5,088,252 | $846.94M | Insider |
James Healy | 3.56% | 4,696,844 | $781.79M | Insider |
Jpmorgan Chase Co | 3.51% | 4,632,029 | $771.00M | Institution |
Farallon Capital Management LLC | 3.45% | 4,557,309 | $758.56M | Institution |
Fred Alger Management LLC | 3.04% | 4,012,000 | $667.80M | Institution |